<DOC>
	<DOCNO>NCT00297388</DOCNO>
	<brief_summary>The purpose study assess time patient relapse switched oral antipsychotic one two dose long-acting risperidone injection ( shot ) . Risperidone use successfully treat schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>A Study How Long Takes Patient Relapse After Switching From Oral Antipsychotic One Two Doses Long-acting Risperidone Injections Patients With Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>Results study older long-acting injectable antipsychotic ( risperidone ) show patient tend relapse ( mean start symptom ) give low dos . However , increase dose may cause side effect . This study measure time relapse 52-week period patient schizophrenia schizoaffective disorder switch oral antipsychotic ( one take mouth ) one two dose long-acting risperidone injection ( shot ) . The patient assign dose either 25 50 milligram per injection every 2 week . Patients continue take usual oral antipsychotic medication 3 week follow first injection . After 3-week period , receive injectable risperidone . Patients ask question visit help determine effectiveness drug assess Clinical Global Impression Scale Positive Negative Syndrome Scale . The safety drug base patient sign symptom assess accord Extrapyramidal Symptom Rating Scale self-reported treatment-emergent adverse event . Long-acting risperidone injection , 25 50 milligram per injection , every 2 week 52 week . Patients continue take current oral antipsychotic 3 week follow first injection risperidone .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients diagnose schizophrenia schizoaffective disorder stable respect disease symptoms medical condition stable oral antipsychotic drug ( except clozapine ) 4 week study patient identify relative acquaintance complete questionnaire additional information patient female , use birth control . Patient eligible currently hospitalize , treat acute diseaserelated crisis within past 4 week risk self others use injectable antipsychotic drug electroconvulsive therapy within past 6 month , currently use carbamazepineor oral antipsychotic drug dose high 8 milligram per day risperidone equivalent , longacting risperidone earlier study , clozapine , use investigational drug within 30 day , electroconvulsive therapy within past 6 month presence liver kidney damage history neuroleptic malignant syndrome pregnant breastfeeding use birth control abuse drug alcohol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>long-acting risperidone</keyword>
	<keyword>intramuscular injection risperidone</keyword>
	<keyword>risperidone</keyword>
</DOC>